| Literature DB >> 11980634 |
William J LaRochelle1, Michael Jeffers, Jose R F Corvalan, Xiao-Chi Jia, Xiao Feng, Sandra Vanegas, Justin D Vickroy, Xiao-Dong Yang, Francine Chen, Gadi Gazit, Jane Mayotte, Jennifer Macaluso, Beth Rittman, Frank Wu, Mohan Dhanabal, John Herrmann, Henri S Lichenstein.
Abstract
Platelet-derived growth factor (PDGF) has been directly implicated in developmental and physiological processes, as well as in human cancer and other proliferative disorders. We have recently isolated and characterized a novel protease-activated member of the PDGF family, PDGF D. PDGF D has been shown to be proliferative for cells of mesenchymal origin, signaling through PDGF receptors. Comprehensive and systematic PDGF D transcript analysis revealed expression in many cell lines derived from ovarian, renal, and lung cancers, as well as from astrocytomas and medulloblastomas. beta PDGF receptor profiling further suggested autocrine signaling in several brain tumor cell lines. PDGF D transforming ability and tumor formation in SCID mice was further demonstrated. Exploiting a sensitive PDGF D sandwich ELISA using fully human monoclonal antibodies, PDGF D was detected at elevated levels in the sera of ovarian, renal, lung, and brain cancer patients. Immunohistochemical analysis confirmed PDGF D localization to ovarian and lung tumor tissues. Together, these data demonstrate that PDGF D plays a role in certain human cancers.Entities:
Mesh：
Substances：
Year: 2002 PMID： 11980634
Source DB: PubMed Journal: Cancer Res ISSN： 0008-5472 Impact factor: 12.701